Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1602 | 2020 |
The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 578 (7793), 122-128, 2020 | 901 | 2020 |
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer MKH Hong*, G Macintyre*, DC Wedge*, P Van Loo, K Patel, S Lunke, ... Nature Communications 6, 2015 | 397 | 2015 |
Copy number signatures and mutational processes in ovarian carcinoma G Macintyre, TE Goranova, D De Silva, D Ennis, AM Piskorz, M Eldridge, ... Nature genetics 50 (9), 1262-1270, 2018 | 393 | 2018 |
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ... Cell 184 (8), 2239-2254. e39, 2021 | 346* | 2021 |
Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells L Pirola, A Balcerczyk, RW Tothill, I Haviv, A Kaspi, S Lunke, M Ziemann, ... Genome research 21 (10), 1601-1615, 2011 | 245 | 2011 |
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ... Nature Genetics 52 (6), 582-593, 2020 | 164 | 2020 |
Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array H Naeem, NC Wong, Z Chatterton, MKH Hong, JS Pedersen, ... BMC genomics 15, 1-15, 2014 | 155 | 2014 |
is-rSNP: a novel technique for in silico regulatory SNP detection G Macintyre, J Bailey, I Haviv, A Kowalczyk Bioinformatics 26 (18), i524-i530, 2010 | 152 | 2010 |
A pan-cancer compendium of chromosomal instability RM Drews, B Hernando, M Tarabichi, K Haase, T Lesluyes, PS Smith, ... Nature 606 (7916), 976-983, 2022 | 142 | 2022 |
Prognostic gene expression signature for high-grade serous ovarian cancer J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, ... Annals of Oncology 31 (9), 1240-1250, 2020 | 110 | 2020 |
Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27+ Cell Population with Progenitor Characteristics S Choudhury, V Almendro, VF Merino, Z Wu, R Maruyama, Y Su, ... Cell stem cell, 2013 | 109 | 2013 |
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads J Schröder, A Hsu, SE Boyle, G Macintyre, M Cmero, RW Tothill, ... Bioinformatics 30 (8), 1064-1072, 2014 | 101 | 2014 |
Sequencing Structural Variants in Cancer for Precision Therapeutics G Macintyre, B Ylstra, JD Brenton Trends in Genetics 32 (9), 530-542, 2016 | 99 | 2016 |
A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance N Sapre, G Macintyre, M Clarkson, H Naeem, M Cmero, A Kowalczyk, ... British journal of cancer 114 (4), 454-462, 2016 | 96 | 2016 |
Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer N Sapre, MKH Hong, G Macintyre, H Lewis, A Kowalczyk, AJ Costello, ... PloS one 9 (4), e91729, 2014 | 60 | 2014 |
Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancer M Fankhauser, Y Tan, G Macintyre, I Haviv, MKH Hong, A Nguyen, ... Clinical Cancer Research 20 (21), 5547-5557, 2014 | 58 | 2014 |
Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE) A Talhouk, J George, C Wang, T Budden, TZ Tan, DS Chiu, S Kommoss, ... Clinical Cancer Research 26 (20), 5411-5423, 2020 | 54 | 2020 |
Genomic landscape of platinum resistant and sensitive testicular cancers C Loveday, K Litchfield, PZ Proszek, AJ Cornish, F Santo, M Levy, ... Nature Communications 11 (1), 2189, 2020 | 52 | 2020 |
Inferring structural variant cancer cell fraction M Cmero, K Yuan, CS Ong, J Schröder, NM Corcoran, T Papenfuss, ... Nature communications 11 (1), 730, 2020 | 46* | 2020 |